Abstract
Ebola virus disease (EVD) has been a great concern worldwide because of its high mortality. EVD usually manifests with fever, diarrhea and vomiting, as well as disseminated intravascular coagulation (DIC). To date, there is neither a licensed Ebola vaccine nor a promising therapeutic agent, although clinical trials are ongoing. For replication inside the cell, Ebola virus (EBOV) must undergo the proteolytic processing of its surface glycoprotein in the endosome by proteases including cathepsin B (CatB), followed by the fusion of the viral membrane and host endosome. Thus, the proteases have been considered as potential targets for drugs against EVD. However, no protease inhibitor has been presented as effective clinical drug against it. A synthetic serine protease inhibitor, nafamostat mesilate (NM), reduced the release of CatB from the rat pancreas. Furthermore, it has anticoagulant activities, such as inhibition of the factor VIIa complex, and has been used for treating DIC in Japan. Thus, NM could be considered as a drug candidate for the treatment of DIC induced by EBOV infection, as well as for the possible CatB-related antiviral action. Moreover, the drug has a history of large-scale production and clinical use, and the i...Continue Reading
References
Apr 1, 1986·American Journal of Hematology·Y TakemotoS Shibata
Jan 1, 1985·Haemostasis·Y HitomiS Fujii
Dec 1, 1987·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Y KoshiyamaM Iwaki
Oct 13, 1981·Biochimica Et Biophysica Acta·S Fujii, Y Hitomi
Jul 1, 1984·Japanese Journal of Pharmacology·T AoyamaM Fujita
Jan 1, 1983·Haemostasis·T YoshikawaM Kondo
Jan 1, 1994·British Journal of Pharmacology·S MutoY Asano
Apr 15, 1994·Thrombosis Research·M UchibaK Takatsuki
Jan 19, 2002·Journal of Comparative Pathology·M BrayJ W Huggins
Dec 20, 2003·Lancet·Thomas W GeisbertGeorge P Vlasuk
Apr 16, 2005·Science·Kartik ChandranJames M Cunningham
Nov 16, 2005·Nephron. Physiology·Shigeaki MutoEiji Kusano
Oct 23, 2009·Journal of Virology·Anthony C WongKartik Chandran
Apr 4, 2012·Viruses·Catherine L HuntWendy Maury
Dec 14, 2012·PLoS Neglected Tropical Diseases·Andrea MarziHeinz Feldmann
Jan 25, 2013·Viruses·Heike Hofmann-WinklerStefan Pöhlmann
Dec 6, 2014·Lancet·Dara Mohammadi
Mar 31, 2015·Lancet·Andrea Marzi, Darryl Falzarano
Citations
Oct 20, 2015·F1000Research·Sean EkinsPeter Madrid
Apr 19, 2020·Molecular Biology Reports·George Zaki Ghali, Michael George Zaki Ghali
Jun 20, 2020·Journal of Thrombosis and Haemostasis : JTH·Toshiaki IbaJecko Thachil
Aug 28, 2018·Frontiers in Immunology·Kuldeep DhamaWanpen Chaicumpa
Aug 19, 2017·Virology Journal·Winke Van der GuchtPeter L Delputte
Sep 26, 2019·Frontiers in Oncology·Xi ChenYuanliang Yan
Jul 1, 2020·Neural Regeneration Research·George Zaki Ghali, Michael George Zaki Ghali
Mar 15, 2020·Military Medical Research·Yan-Rong GuoYan Yan
Dec 4, 2020·World Journal of Clinical Cases·Masaki OkajimaHideyuki Mouri
Apr 22, 2020·The Journal of Infection·Huilan TuJifang Sheng
Feb 23, 2021·Journal of Molecular Structure·Deep BhowmikDiwakar Kumar
Oct 10, 2020·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Mansab Ali SaleemiEng Hwa Wong
Nov 18, 2020·Respiratory Medicine·Mukta AgrawalAmit Alexander